Nearly 10,000 experts and students focused on infectious disease research, treatment, and public-health strategy are ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing d | Dianthus and Boehringer Ingelheim ...

AstraZeneca's booth is seen during an expo in Beijing in September. [Photo/VCG] China is rapidly emerging as a powerhouse for innovative drug development, a significant shift in the global ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim ...

In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus ...

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem ...